Atomo Secures US$6M from the Global Health Investment Fund
The investment will support scale up of Atomo’s global health activities.
January 13, 2016 (SYDNEY and NEW YORK): The Global Health Investment Fund (GHIF) announced today that it has provided a US$6 million [A$8.5 million] loan to Atomo Diagnostics (Atomo) to support scale-up of Atomo’s production operations and expansion of commercial activities related to the AtomoRapid™ rapid diagnostic test (RDT) platform. Funds will also be used to commercialize a self-test solution for HIV and other infectious diseases.
Read full article here.